-
A panel of experts advising the Food and Drug Administration will weigh the safety and effectiveness of the COVID-19 vaccine from Pfizer and BioNTech in a…
-
In a 17-4 vote, an expert committee concluded that the scientific evidence supports the authorization of the COVID-19 vaccine from Pfizer and BioNTech for emergency use during the pandemic.
-
The vaccine produced by Pfizer and BioNTech is the first to be authorized by Canadian health officials. The decision makes Canada just the third country in the world to grant such an authorization.
-
The Food and Drug Administration finds "no specific safety concerns" that would stand in the way of authorization of the vaccine for emergency use. Effectiveness is 95% after two doses.
-
Almost a year ago, "HealthLink on Air" first talked about a novel coronavirus with Upstate’s chief of infectious disease, Dr. Stephen Thomas, who is also…
-
A British regulatory agency approved the Pfizer/BioNTech vaccine Wednesday. It could be dispersed within days to the neediest people, government officials said.
-
The pharmaceutical giant and partner BioNTech announced Friday that they are submitting a formal request to the Food and Drug Administration, just days after the vaccine was shown to be 95% effective.
-
The vaccine was found to be 95% effective in an updated study analysis. Safety data required by the Food and Drug Administration showed no serious concerns, the company said.
-
One of the two leading vaccine candidates requires deep, deep freezing. Here's how communities are working to solve for this and how the new Moderna vaccine could help.
-
Stocks surged after Pfizer said its experimental vaccine was more than 90% effective and after former Vice President Joe Biden was elected president.